The European Cancer Imaging Initiative aims to advance innovation and deployment of digital technologies in cancer treatment and care, to achieve more precise and faster clinical decision-making, diagnostics and treatments. The European Cancer Imaging Initiative is one of the flagships of the EBCP, Europe’s Beating Cancer Plan, which endeavors to make the most of the potential of data and digital technologies such as AI and High-Performance Computing to fight cancer.
Medexprim is proud to participate to such an ambitious initiative fostering predictive medicine for cancer patients: its cornerstone will be a federated European infrastructure for cancer images data, developed by the EUCAIM multicentric project.
More information on the European Commission website
Read the European Commission’s Press Release